Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 10, 2015, Pages 1721-1731

  Gauthier, Simon David ^a,b   Leboeuf, Dominique ^a   Manuguerra Gagné, Renaud ^a   Gaboury, Louis ^c   Guimond, Martin ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

CD4+ T lymphocytes; Dendritic cells; Flt3 ligand; Graft versus host disease; Homeostatic proliferation; Interleukin 7; Stromal derived factor 1

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CXCR4; FLT3 LIGAND; GLYCOPROTEIN P 15095; MESSENGER RNA; RECOMBINANT INTERLEUKIN 7; RECOMBINANT PROTEIN; RECOMBINANT STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; CXCL12 PROTEIN, HUMAN; FLT3 LIGAND PROTEIN; IL7 PROTEIN, HUMAN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN-7 RECEPTOR, ALPHA CHAIN; INTERLEUKIN-7, MOUSE; MEMBRANE PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ARTICLE; BONE MARROW SUPPRESSION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL REGENERATION; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HOMEOSTASIS; HOMEOSTATIC PROLIFERATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; STROMA CELL; T LYMPHOCYTE ACTIVATION; ALLOTRANSPLANTATION; ANIMAL; BLOOD; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CD4 LYMPHOCYTE COUNT; COMBINATION DRUG THERAPY; CYTOTOXIC T LYMPHOCYTE; DEFICIENCY; DRUG POTENTIATION; GRAFT VS HOST DISEASE; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW TRANSPLANTATION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL12; DENDRITIC CELLS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-7; LYMPHOCYTE DEPLETION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-7; RECOMBINANT PROTEINS; STROMAL CELLS; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 84941316714     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.06.019     Document Type: Article

References (55)

1. Ferrara J.L., Deeg H.J. Graft-versus-host disease. N Engl J Med 1991, 324:667-674.
2. Seddik M., Seemayer T.A., Lapp W.S. The graft-versus-host reaction and immune function. II. Recruitment of pre-T-cells in vivo by graft-versus-host-induced dysplastic thymuses following irradiation and bone marrow treatment. Transplantation 1984, 37:286-290.
3. Muller-Hermelink H.K., Sale G.E., Borisch B., et al. Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. Am J Pathol 1987, 129:242-256.
4. Bleyer W., Blaese R.M., Bujak J.S., et al. Long-term remission from acute myelogenous leukemia after bone marrow transplantation and recovery from acute graft-versus-host reaction and prolonged immunoincompetence. Blood 1975, 45:171-181.
5. Storek J., Witherspoon R.P., Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995, 16:413-425.
6. Mackall C.L., Fleisher T.A., Brown M.R., et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997, 89:3700-3707.
7. Nakajima H., Shores E.W., Noguchi M., Leonard W.J. The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J Exp Med 1997, 185:189-195.
8. Soares M.V., Borthwick N.J., Maini M.K., et al. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J Immunol 1998, 161:5909-5917.
9. Labrecque N., Whitfield L.S., Obst R., et al. How much TCR does a T cell need?. Immunity 2001, 15:71-82.
10. Goldrath A.W., Bevan M.J. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 1999, 11:183-190.
11. Napolitano L.A., Grant R.M., Deeks S.G., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001, 7:73-79.
12. Fry T.J., Connick E., Falloon J., et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001, 97:2983-2990.
13. Tan J.T., Dudl E., Leroy E., et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 2001, 98:8732-8737.
14. Rosenberg S.A., Sportès C., Ahmadzadeh M., et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother 2006, 29:313-319.
15. Sportès C., Hakim F.T., Memon S.A., et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008, 205:1701-1714.
16. Fry T.J., Sinha M., Milliron M., et al. Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution. Blood 2004, 104:2794-2800.
17. Guimond M., Veenstra R.G., Grindler D.J., et al. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol 2009, 10:149-157.
18. Hennion-tscheltzoff O., Leboeuf D., Gauthier S.D., et al. TCR triggering modulates the responsiveness and homeostatic proliferation of CD4+ thymic emigrants to IL-7 therapy. Blood 2013, 121:4684-4693.
19. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
20. Kohara H., Omatsu Y., Sugiyama T., et al. Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling. Blood 2007, 110:4153-4160.
21. Greenbaum A., Hsu Y.M., Day R.B., et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 2013, 495:227-230.
22. Dulude G., Roy D.C., Perreault C. The effect of graft-versus-host disease on T cell production and homeostasis. J Exp Med 1999, 189:1329-1342.
23. Gorski J., Chen X., Gendelman M., et al. Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. Blood 2007, 109:5502-5510.
24. Dean R.M., Fry T., Mackall C., et al. Association of serum interleukin-7 levels with the development of acute graft-versus-host disease. J Clin Oncol 2008, 26:5735-5741.
25. Thiant S., Yakoub-agha I., Magro L., et al. Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse. Bone Marrow Transplant 2010, 45:1546-1552.
26. Banovic T., Markey K.A., Kuns R.D., et al. Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells. J Immunol 2009, 182:912-920.
27. Shono Y., Ueha S., Wang Y., et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood 2010, 115:5401-5411.
28. Yao Y., Song X., Cheng H., et al. Dysfunction of bone marrow vascular niche in acute graft-versus-host disease after MHC-haploidentical bone marrow transplantation. PLoS One 2014, 9:e104607.
29. Nagasawa T., Hirota S., Tachibana K., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
30. Zou Y.R., Kottmann A.H., Kuroda M., et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
31. Lataillade J.J., Clay D., Bourin P., et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 2002, 99:1117-1129.
32. Guimond M., Freud A.G., Mao H.C., et al. In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol 2010, 184:2769-2775.
33. Higano C.S., Vogelzang N.J., Sosman J.A., et al. Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer. Clin Cancer Res 2004, 10:1219-1225.
34. Zou W., Machelon V., Coulomb-l'hermin A., et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001, 7:1339-1346.
35. Luther S.A., Bidgol A., Hargreaves D.C., et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002, 169:424-433.
36. Garnica M.R., de Moraes L.V., Rizzo L.V., de Andrade H.F. Supplementation of CXCL12 (CXCL12) induces homing of CD11c+ dendritic cells to the spleen and enhances control of Plasmodium berghei malaria in BALB/c mice. Immunology 2005, 115:399-406.
37. Takebayashi M., Amakawa R., Tajima K., et al. Blood dendritic cells are decreased in acute graft-versus-host disease. Bone Marrow Transplant 2004, 33:989-996.
38. Loyer V., Fontaine P., Pion S., et al. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. J Immunol 1999, 163:6462-6467.
39. Nguyen Hoang A.T., Liu H., Juaréz J., et al. Stromal cell-derived CXCL12 and CCL8 cooperate to support increased development of regulatory dendritic cells following Leishmania infection. J Immunol 2010, 185:2360-2371.
40. McKenna H.J., Stocking K.L., Miller R.E., et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000, 95:3489-3497.
41. Chklovskaia E., Nissen C., Landmann L., et al. Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A. Blood 2001, 97:1027-1034.
42. Alpdogan O., Muriglan S.J., Eng J.M., et al. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 2003, 112:1095-1107.
43. Mensen A., Johrens K., Anagnostopoulos I., et al. Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT. Blood 2014, 124:963-972.
44. Shono Y., Shiratori S., Kosugi-Kanaya M., et al. Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2014, 20:495-500.
45. von Bonin M., Bornhauser M. Concise review: the bone marrow niche as a target of graft versus host disease. Stem Cells 2014, 32:1420-1428.
46. Qian S., Lu L., Fu F., et al. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation 1998, 65:1590-1598.
47. Blazar B.R., McKenna H.J., Panoskaltsis-Mortari A., Taylor P.A. Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality. Biol Blood Marrow Transplant 2001, 7:197-207.
48. Sinha M.L., Fry T.J., Fowler D.H., et al. Interleukin 7 worsens graft-versus-host disease. Blood 2002, 100:2642-2649.
49. Pooley J.L., Heath W.R., Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol 2001, 166:5327-5330.
50. Dudziak D., Kamphorst A.O., Heidkamp G.F., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315:107-111.
51. Jinquan T., Quan S., Jacobi H.H., et al. CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10. Immunology 2000, 99:402-410.
52. Bilsborough J., George T.C., Norment A., Viney J.L. Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 2003, 108:481-492.
53. Chung B., Dudl E., Toyama A., et al. Weinberg. Importance of interleukin-7 in the development of experimental graft-versus-host disease. Biol Blood Marrow Transplant 2008, 14:16-27.
54. Gendelman M., Hecht T., Logan B., et al. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. J Immunol 2004, 172:3328-3336.
55. Perales M.A., Goldberg J.D., Yuan J., et al. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood 2012, 120:4882-4891.